Sartorius Stedim Biotech S.A. proposes €0.69/share dividend (€177.00, -4.40)
StreetAccount Summary - Trading higher/lower: EU mid-morning
Transcript Intelligence: Sartorius Stedim Biotech Q4 Earnings Guidance
Transcript Intelligence: Sartorius Stedim Biotech Q4 Earnings Q&A
Transcript Intelligence: Sartorius Stedim Biotech Q4 Earnings Themes
Sartorius Stedim Biotech downgraded to neutral from buy at Goldman Sachs (€214.30, 0.00)
Powered by FactSet Research Systems Inc.